Notas del episodio
Speaker:
Irwin Simon. Chairman & CEO, Tilray Brands
Discussion Points
- Impact from spending bill (CR) on HDD9 drinks strategy
- Continued progress improvement in the beer and liquor business
- Outlook for the international medical cannabis business (MMJ)
- State of Tilray’s position in Canada’s rec market
- Balance sheet strength and cash deployment plans
- A cannabis company or a CPG company?
- How TLRY can benefit from being the most liquid cannabis stock in NASDAQ?
Palabras clave
CannabisReschedulingInvestingC SuiteTilray MarijuanadispensaryDispensariesDEAMSOsSchedule 3HHSschedule IIICanadaFloridaGermanyPharmacyClinicseuropepatientsBerlinOhiovapevapingvapesschedule 1Zuanic & associatesPablo ZuanicHSAInvesting CannabisIrwin SimonrepublicanDemocratsPennsylvaniaHemp DrinkshempFarm BillIsraelLas VegasSafe bankingSafer bankingHemp Derivativescoffee shopsHemp Beverage AllianceCaliforniaDelawareCannabis lawSpainPortugalPre-RollmichiganMinnesota
Sobre qué lugar trata este episodio
Country